2 May 2016 On the possibility of low cost, adherent therapeutic drug monitoring in oncology
Author Affiliations +
A frequent quantification of drugs concentrations in plasma of patients subject to chemotherapy is seldom performed, mostly because the standard methods (Gas or Liquid Chromatography coupled with Mass Spectroscopy) are expensive and time consuming. In this paper we report the approach pursued in one of the research units of the EU project RAMAN4CLINICS to tackle the problem of a low cost, time adherent quantification of drugs used for oncological patients using a Surface Enhanced Raman Scattering (SERS) spectroscopy. More specifically, the issues concerning the repeatability of the nanostructured substrates will be presented and some promising results to increase the selectivity of the measures toward specific drugs will be discussed, with examples concerning one cytotoxic agent, Irinotecan and one kinase inhibitor, Sunitinib.
© (2016) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Silvia Dalla Marta, Silvia Dalla Marta, Stefano Fornasaro, Stefano Fornasaro, Aleksandra Jaworska, Aleksandra Jaworska, Giuseppe Toffoli, Giuseppe Toffoli, Alois Bonifacio, Alois Bonifacio, Valter Sergo, Valter Sergo, } "On the possibility of low cost, adherent therapeutic drug monitoring in oncology", Proc. SPIE 9887, Biophotonics: Photonic Solutions for Better Health Care V, 98870G (2 May 2016); doi: 10.1117/12.2225232; https://doi.org/10.1117/12.2225232

Back to Top